Günther C - Search Results

1

Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?

Heinen A, Schnabel A, Brück N, Smitka M, Wolf C, Lucas N, Dollinger S, Hahn G, Günther C, Berner R, Lee-Kirsch MA, Schuetz C. Heinen A, et al. Among authors: gunther c. Rheumatology (Oxford). 2021 Apr 6;60(4):e136-e138. doi: 10.1093/rheumatology/keaa657. Rheumatology (Oxford). 2021. PMID: 33200187 No abstract available.

2

Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.

Günther C, Meurer M, Stein A, Viehweg A, Lee-Kirsch MA. Günther C, et al. Dermatology. 2009;219(2):162-6. doi: 10.1159/000222430. Epub 2009 May 28. Dermatology. 2009. PMID: 19478477

3

Innate immune processes in lupus erythematosus.

Aringer M, Günther C, Lee-Kirsch MA. Aringer M, et al. Among authors: gunther c. Clin Immunol. 2013 Jun;147(3):216-22. doi: 10.1016/j.clim.2012.11.012. Epub 2012 Dec 12. Clin Immunol. 2013. PMID: 23290784 Review.

4

Aicardi-Goutières syndrome: a model disease for systemic autoimmunity.

Lee-Kirsch MA, Wolf C, Günther C. Lee-Kirsch MA, et al. Among authors: gunther c. Clin Exp Immunol. 2014 Jan;175(1):17-24. doi: 10.1111/cei.12160. Clin Exp Immunol. 2014. PMID: 23786362 Free PMC article. Review.

5

Systemic involvement in TREX1-associated familial chilblain lupus.

Günther C, Hillebrand M, Brunk J, Lee-Kirsch MA. Günther C, et al. J Am Acad Dermatol. 2013 Oct;69(4):e179-81. doi: 10.1016/j.jaad.2013.04.020. J Am Acad Dermatol. 2013. PMID: 24034389 No abstract available.

6

Deregulated type I IFN response in TREX1-associated familial chilblain lupus.

Peschke K, Friebe F, Zimmermann N, Wahlicht T, Schumann T, Achleitner M, Berndt N, Luksch H, Behrendt R, Lee-Kirsch MA, Roers A, Günther C. Peschke K, et al. Among authors: gunther c. J Invest Dermatol. 2014 May;134(5):1456-1459. doi: 10.1038/jid.2013.496. Epub 2013 Nov 22. J Invest Dermatol. 2014. PMID: 24270665 Free article. No abstract available.

7

Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1).

Günther C, Berndt N, Wolf C, Lee-Kirsch MA. Günther C, et al. JAMA Dermatol. 2015 Apr;151(4):426-31. doi: 10.1001/jamadermatol.2014.3438. JAMA Dermatol. 2015. PMID: 25517357

8

[Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].

Günther C, Schmidt F, König N, Lee-Kirsch MA. Günther C, et al. Z Rheumatol. 2016 Mar;75(2):134-40. doi: 10.1007/s00393-015-0027-5. Z Rheumatol. 2016. PMID: 26744186 Review. German.

9

RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA.

Wolf C, Rapp A, Berndt N, Staroske W, Schuster M, Dobrick-Mattheuer M, Kretschmer S, König N, Kurth T, Wieczorek D, Kast K, Cardoso MC, Günther C, Lee-Kirsch MA. Wolf C, et al. Among authors: gunther c. Nat Commun. 2016 May 27;7:11752. doi: 10.1038/ncomms11752. Nat Commun. 2016. PMID: 27230542 Free PMC article.

10

Familial chilblain lupus due to a gain-of-function mutation in STING.

König N, Fiehn C, Wolf C, Schuster M, Cura Costa E, Tüngler V, Alvarez HA, Chara O, Engel K, Goldbach-Mansky R, Günther C, Lee-Kirsch MA. König N, et al. Among authors: gunther c. Ann Rheum Dis. 2017 Feb;76(2):468-472. doi: 10.1136/annrheumdis-2016-209841. Epub 2016 Aug 26. Ann Rheum Dis. 2017. PMID: 27566796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters